trending Market Intelligence /marketintelligence/en/news-insights/trending/_EfWDlD8KU75cTih4MDJ6Q2 content esgSubNav
In This List

Fortress Biotech unit closes $94.5M private placement financing

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Fortress Biotech unit closes $94.5M private placement financing

Fortress Biotech Inc.'s subsidiary Mustang Bio, Inc. secured $94.5 million, prior to expenses and fees, in a private placement financing.

The financing allows the company to expand its chimeric antigen receptor engineered T cells immunotherapy pipeline by exploring additional applications in areas outside of the company's initial focus on brain cancer and acute myeloid leukemia.

OPN Capital Markets acted as sole placement agent for the transaction.